Lack of tax transparency in '10 may put pharma off Puerto Rico
The lack of transparency when Puerto Rico imposed a new tax in 2010 may deter drugmakers from expanding on the island, a report found.
Archives for January 12, 2012
Indian CRAMS sector to fuel export growth, CARE says
Outsourcing to Indian CRAMS and bulk drug businesses will drive the country’s export growth, a credit rating agency said.
Injectables maker NantWorks will give Pfizer's old Indiana facility an $85.5m makeover
NantWorks has unveiled plans to pump $85.5m into a new oncology and critical care injectables manufacturing plant in Terre Haute, Indiana.
Big preclinical CROs stuck in tox time warp says upbeat Cyprotex CEO
Cyprotex says bigger preclinical CROs are stuck in toxicity testing ‘time warp’, citing drug industry demand for innovative cellular methods as key to its second half performance.
UK Ab maker extends dye label license with Lab Technologies
Custom antibody manufacturer Cambridge Research Biochemicals (CRB) has expanded its range of labelling dyes through a new agreement with supplier Life Technologies.
Clinigen inks antiretroviral API production pact with PCAS
Clinigen and PCAS have inked a long term supply pact for the production of the API for Foscavir.
US team develops H-heterocyles production method with implications for Pharma
US scientists say a new N-heterocycles synthesis method could open door to the production of novel antibiotics, cancer and pain drugs.
Charles River talks up unity, ‘no comments’ takeover reports
Charles River’s CEO has reiterated the importance of integrating its research models and preclinical units but refused to discuss takeover reports.